April 2022 - Page 8 of 28

FridayApr 22, 2022 2:24 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Well Positioned for Opportunity

Flora Growth Corp. (NASDAQ: FLGC) has expanded its portfolio, which spans a range of verticals and diverse revenue streams, with growth largely driven through mergers and acquisitions (“M&As”). With M&As defining its 2021 calendar year, Flora Growth capitalized on global trends, which saw over 63,000 worldwide M&A transactions completed across all industries and sectors as companies sought new avenues for growth amid the pandemic, rising inflation and disrupted supply chains. With two recent acquisitions, Flora Growth “was able to add an estimated $35 million in revenues and $7 million EBITDA. For comparison, back in 2020, the company’s acquisitions generated $28…

FridayApr 22, 2022 2:04 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Poised Amid Strong Support for Nuclear Energy

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is well positioned as clean energy has become a top priority worldwide. A recent article discussing this shines the spotlight on Capitol Hill and strong bipartisan support for nuclear energy. Energy Fuels, a member of the Nuclear Energy Institute (“NEI”), is among the companies paying close attention as hallmark pieces of legislation have demonstrated that carbon-free, always-on nuclear power is an indispensable driver of the clean energy future. The article discusses the “Build Back Better Act, which is currently on the back burner but contains broadly supported climate provisions that include a production…

FridayApr 22, 2022 1:47 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Committed to Becoming Global Leader in Digital Financial Solutions Marketplace

GreenBox (NASDAQ: GBOX), an innovative blockchain ledger fintech company, recently announced its financial results for the three months ended Dec. 31, 2021, (“Q4 FY2021”) and the fiscal year 2021 (“FY2021”). “GreenBox achieved record revenue in 2021 of $26.3 million, an increase of $17.8 million or 208.6% from $8.5 million in 2020. Processing volume for 2021 increased nearly tenfold to approximately $2.0 billion, from $202 million in 2020,” a recent article reads. “2020 unquestionably proved our ability to develop and deploy cutting-edge technology. In 2021, we focused on executing on our strategy to build sustainable scale for our products, while adding…

FridayApr 22, 2022 1:21 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Focused on Advancing Research on Treatments for GBM, Other Cancers

CNS Pharmaceuticals (NASDAQ: CNSP) is leading the charge toward advancing research on the treatment for glioblastoma multiforme (“GBM”) as well as other primary and metastatic brain and CNS cancers. Last year, the company commenced a potentially pivotal clinical trial of its lead product candidate, Berubicin, for the treatment of GBM, dosing its first patients in September. A recent article discussing this reads, “CNS Pharmaceuticals expects to report an interim analysis of the trial when 30-50% of the planned subjects reach six months in-study, potentially in the first half of 2023. The adaptive, multicenter, open-label, randomized, and controlled study will involve…

FridayApr 22, 2022 12:51 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Taking Head-on Approach to Supply Chain Concerns

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is focused on an aggressive approach toward dealing with food supply chain concerns arising from the COVID-19 pandemic’s years-long battering on global economies and the devastation of a region known as the world’s breadbasket during Russia’s ongoing war against Ukraine. “Eat Well Investment Group is stepping up its production of pulse-sourced protein (proteins from plants in a variety of legume families) to help meet the sudden demand for foods that can no longer be obtained from Russia and Ukraine. The company reported that it produced 90,000 metric tons of proteins from legumes…

FridayApr 22, 2022 10:44 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at KCSA Psychedelics Virtual Investor Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the KCSA Psychedelics Virtual Investor Conference. Drysdale’s presentation is slated to begin at 11:00 a.m. ET on Thursday, April 28, 2022, at the live, interactive online event designed to invite investors to ask the company questions in real-time. Interested parties should visit https://ibn.fm/2G8rh to register for the conference and access the webcast. The archived webcast will also be available on the company’s investor relations website. To view the full press release, visit https://ibn.fm/Gojf3 About Cybin…

FridayApr 22, 2022 10:28 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) to Release Q4 2021, Year-End Financial and Corporate Report

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, released its fourth quarter 2021 and year-end financial results along with a corporate update on Thursday, April 21, 2022. In conjunction with that, the company has scheduled a Zoom conference call this morning at 10 a.m. ET. Hosting the call will be EverGen CEO Chase Edgelow. The call will be available to anyone who is interested. EverGen is an independent renewable energy producer. The company’s business model is to acquire, develop, build, own or operate renewable natural gas, waste to energy and other related infrastructure projects. To view…

FridayApr 22, 2022 10:06 am

QualityStocksNewsBreaks — AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) to Conduct Key Research with TransBIOTech, Names New COO

AREV Life Sciences Global (CSE: AREV) (OTC: AREVF) has partnered with TransBIOTech, a publicly supported preclinical research organization, in a project to research cannabinoids and other early-stage commercial programs. TransBIOTech works with and is supported by the Canadian government through the Natural Sciences and Engineering Research Council (“NSERC”) in collaboration with the Canadian Institutes of Health Research (“CIHR”). AREV and TransBIOTech will work together to establish a foundation for further research focused on specific understandings of the company’s recent chemical entity development including initial toxicity, pharmacokinetics and metabolism modeling essential for human studies and eventual commercialization. In addition, AREV also…

Site Search

Company Search

Month: April 2022